Evidence map›Paper›PMID 29300933›Full record

ArticleNucleic acids research2018

Structural characterization of the Asf1-Rtt109 interaction and its role in histone acetylation.

Lukas Lercher, Nataliya Danilenko, John Kirkpatrick, Teresa Carlomagno

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanism of ASF1 engagement by CDAN1.Nature communications · 2025
    Article
  4. Article
  5. Mechanism of ASF1 Inhibition by CDAN1.bioRxiv : the preprint server for biology · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lukas LercherBMWZ and Institute of Organic Chemistry, Leibniz Universität Hannover, Hannover, Germany.
Nataliya DanilenkoBMWZ and Institute of Organic Chemistry, Leibniz Universität Hannover, Hannover, Germany.
John KirkpatrickBMWZ and Institute of Organic Chemistry, Leibniz Universität Hannover, Hannover, Germany.
Teresa CarlomagnoBMWZ and Institute of Organic Chemistry, Leibniz Universität Hannover, Hannover, Germany.
Leibniz University Hannover · DEHelmholtz Centre for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetylation of histone H3 at lysine-56 by the histone acetyltransferase Rtt109 in lower eukaryotes is important for maintaining genomic integrity and is required for C. albicans pathogenicity. Rtt109 is activated by association with two different histone chaperones, Vps75 and Asf1, through an unknown mechanism. Here, we reveal that the Rtt109 C-terminus interacts directly with Asf1 and elucidate the structural basis of this interaction. In addition, we find that the H3 N-terminus can interact via the same interface on Asf1, leading to a competition between the two interaction partners. This, together with the recruitment and position of the substrate, provides an explanation of the role of the Rtt109 C-terminus in Asf1-dependent Rtt109 activation.

Indexed as

Protein Processing, Post-TranslationalAcetylationCell Cycle ProteinsHistone AcetyltransferasesHistonesMagnetic Resonance SpectroscopyModels, MolecularMolecular ChaperonesProtein BindingProtein DomainsSaccharomyces cerevisiae ProteinsSubstrate SpecificityASF1 protein, S cerevisiaeCell Cycle ProteinsHistone AcetyltransferasesHistonesMolecular ChaperonesRtt109 protein, S cerevisiaeSaccharomyces cerevisiae Proteins

Identifiers

PMID29300933
PMCPMC5861439
OpenAlexW2776737967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.